SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001655759-22-000076
Filing Date
2022-12-19
Accepted
2022-12-19 17:26:51
Documents
4
Period of Report
2022-12-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_167148879612982.html 3  
1 FORM 3 wf-form3_167148879612982.xml 3 1776
2 EXHIBIT 24.1 DOCUMENT - EVERETT CUNNINGHAM cunninghampoa12_16x2022.htm EX-24 980
3 GRAPHIC cunninghampoa12_16x2022002.jpg GRAPHIC 30295
4 GRAPHIC cunninghampoa12_16x2022001.jpg GRAPHIC 239678
  Complete submission text file 0001655759-22-000076.txt   376382
Mailing Address C/O QUEST DIAGNOSTICS 500 PLAZA DRIVE SECAUCUS NJ 07094
Business Address
Cunningham Everett (Reporting) CIK: 0001564777 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38672 | Film No.: 221472151

Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Issuer) CIK: 0001655759 (see all company filings)

IRS No.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations